Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Angela Orcurto"'
Autor:
Rebecca Kristeleit, Juan Martin-Liberal, Kristen Spencer, Janice M Mehnert, Maria Vieito, Elizabeth J Davis, Angela Orcurto, Thomas Condamine, Daniel C Cho, Jennifer Pulini, Rowan E Miller, Sarah P Blagden, Dominik Berthold, Dana B Cardin, Prashanth Hari Dass, John E Janik, Jason Clark, Xuejun Chen
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 10 (2022)
Background OX40 is a costimulatory receptor upregulated on antigen-activated T cells and constitutively expressed on regulatory T cells (Tregs). INCAGN01949, a fully human immunoglobulin G1κ anti-OX40 agonist monoclonal antibody, was designed to pro
Externí odkaz:
https://doaj.org/article/ac1ed19fc2ac410aa1aabfc845b35fef
Autor:
Sara Colomer-Lahiguera, Denise Bryant-Lukosius, Sarah Rietkoetter, Lorraine Martelli, Karin Ribi, Donna Fitzpatrick-Lewis, Diana Sherifali, Angela Orcurto, Rosalyn Juergens, Manuela Eicher
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 4, Iss 1, Pp 1-9 (2020)
Abstract Context Immune-checkpoint inhibitors (ICI) have shown significant benefits for overall survival across various cancer types. Patient-reported outcomes (PROs) are assessed in clinical trials as a measure of efficacy. However, it remains uncle
Externí odkaz:
https://doaj.org/article/ee546c5e033a4c6dab7f30c36e5c21cd
Autor:
Carole Bandiera, Evelina Cardoso, Isabella Locatelli, Antonia Digklia, Khalil Zaman, Antonella Diciolla, Valérie Cristina, Athina Stravodimou, Aedo Lopez Veronica, Ana Dolcan, Apostolos Sarivalasis, Aikaterini Liapi, Hasna Bouchaab, Angela Orcurto, Jennifer Dotta-Celio, Solange Peters, Laurent Decosterd, Nicolas Widmer, Dorothea Wagner, Chantal Csajka, Marie Paule Schneider
Publikováno v:
JMIR Research Protocols, Vol 10, Iss 6, p e30090 (2021)
BackgroundThe strengthening or substitution of intravenous cytotoxic chemotherapy cycles by oral targeted anticancer therapies, such as protein kinase inhibitors (PKIs), has provided impressive clinical benefits and autonomy as well as a better quali
Externí odkaz:
https://doaj.org/article/04775837df1f491490dee20da4b49c14
Autor:
Thierry Kuntzer, Olivier Michielin, George Coukos, Alexandre Harari, Stefan Zimmermann, Maria Ochoa de Olza, Denis Comte, Angela Orcurto, Andreas Hottinger, Benita Wolf, Blanca Navarro Rodrigo, Aymeric Auger, Virginie Zimmer, Philippe Gannon, Lana Kandalaft, Lionel Trueb
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Background Adoptive cell therapy (ACT) using tumor-infiltrating lymphocytes (TILs) is a promising experimental immunotherapy that has shown high objective responses in patients with melanoma. Current protocols use a lymphodepletive chemotherapy befor
Externí odkaz:
https://doaj.org/article/5be9d337c28b432996f3329388ef82cf
Publikováno v:
Case Reports in Dermatology, Vol 6, Iss 1, Pp 80-84 (2014)
Sebaceous carcinoma (SC) is an uncommon neoplasm manifesting itself either in the eyelid or extraocularly in the head and neck area. Surgery is the standard of care. Irradiation is rarely proposed as monotherapy but is frequently administered as an a
Externí odkaz:
https://doaj.org/article/72c768e42f924cc39cbe800557b2af9d
Publikováno v:
Case Reports in Urology, Vol 2013 (2013)
Kidney lesions may be difficult to diagnose only by radiological exams, often requiring proof by tissue biopsy. Moreover, if enlarged regional lymph nodes are also present, the spectrum of differential diagnoses is even greater. The role of regional
Externí odkaz:
https://doaj.org/article/9b84b826256f44cc847d6eb9abf144fd
Autor:
Tu Nguyen-Ngoc, Karim Abdelhamid, Nils Degrauwe, Sabine Galland, Andrea Serena, Melissa Christofis, Nuria Mederos, Hasna Bouchaab, Antonella Diciolla, Nassim Dris, Angela Orcurto, Claire Perrinjaquet, Marc Schnetz, Sofiya Latifyan, Laureline Wetterwald, Ruth Gabriela Herrera Gómez, Valérie Cristina, Apostolos Sarivalasis, Olivier Michielin, Dominik Berthold, Antonia Digklia, Anna Dorothea Wagner, Khalil Zaman, Solange Peters, Athina Stravodimou
Publikováno v:
Revue Médicale Suisse. 19:52-57
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b36853729eba92fe90735f2e731077a0
https://doi.org/10.53738/revmed.2023.19.809-10.52
https://doi.org/10.53738/revmed.2023.19.809-10.52
Autor:
George Coukos, Melita Irving, Denarda Dangaj Laniti, Santiago J. Carmona, Lana E. Kandalaft, Alexandre Harari, Urania Dafni, Christine Sempoux, Stefan Zimmermann, Mikaël J. Pittet, Sylvie Rusakiewicz, Periklis Foukas, Sarah E. Warren, Thomas Smith, Marius Messemaker, Zoi Tsourti, Georgia Dimopoulou, Jean Bourhis, Niklaus Schaefer, John Prior, Clarisse Dromain, Rafael Duran, Khalil Zaman, Apostolos Sarivalasis, Dominik R. Berthold, Blanca Navarro Rodrigo, Eleonora Ghisoni, Martina Imbimbo, Angela Orcurto, Raphael Genolet, Fabrizio Benedetti, Aodrenn Spill, Jesus Corria-Osorio, Massimo Andreatta, Isaac Crespo, David Barras, Maria Ochoa de Olza, Catherine Ronet, Fernanda G. Herrera
Developing strategies to inflame tumors is critical for increasing response to immunotherapy. Here, we report that low-dose radiotherapy (LDRT) of murine tumors promotes T-cell infiltration and enables responsiveness to combinatorial immunotherapy in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42361d442a283c57e9ad86282f9855a8
https://doi.org/10.1158/2159-8290.c.6549407.v1
https://doi.org/10.1158/2159-8290.c.6549407.v1
Autor:
George Coukos, Melita Irving, Denarda Dangaj Laniti, Santiago J. Carmona, Lana E. Kandalaft, Alexandre Harari, Urania Dafni, Christine Sempoux, Stefan Zimmermann, Mikaël J. Pittet, Sylvie Rusakiewicz, Periklis Foukas, Sarah E. Warren, Thomas Smith, Marius Messemaker, Zoi Tsourti, Georgia Dimopoulou, Jean Bourhis, Niklaus Schaefer, John Prior, Clarisse Dromain, Rafael Duran, Khalil Zaman, Apostolos Sarivalasis, Dominik R. Berthold, Blanca Navarro Rodrigo, Eleonora Ghisoni, Martina Imbimbo, Angela Orcurto, Raphael Genolet, Fabrizio Benedetti, Aodrenn Spill, Jesus Corria-Osorio, Massimo Andreatta, Isaac Crespo, David Barras, Maria Ochoa de Olza, Catherine Ronet, Fernanda G. Herrera
Supplementary Figure from Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c432a79d8ff8b093481e747e7f942e5
https://doi.org/10.1158/2159-8290.22540574.v1
https://doi.org/10.1158/2159-8290.22540574.v1
Autor:
George Coukos, Melita Irving, Denarda Dangaj Laniti, Santiago J. Carmona, Lana E. Kandalaft, Alexandre Harari, Urania Dafni, Christine Sempoux, Stefan Zimmermann, Mikaël J. Pittet, Sylvie Rusakiewicz, Periklis Foukas, Sarah E. Warren, Thomas Smith, Marius Messemaker, Zoi Tsourti, Georgia Dimopoulou, Jean Bourhis, Niklaus Schaefer, John Prior, Clarisse Dromain, Rafael Duran, Khalil Zaman, Apostolos Sarivalasis, Dominik R. Berthold, Blanca Navarro Rodrigo, Eleonora Ghisoni, Martina Imbimbo, Angela Orcurto, Raphael Genolet, Fabrizio Benedetti, Aodrenn Spill, Jesus Corria-Osorio, Massimo Andreatta, Isaac Crespo, David Barras, Maria Ochoa de Olza, Catherine Ronet, Fernanda G. Herrera
Supplementary Data from Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1fc019e17ebcdfce120dec328cf67e5b
https://doi.org/10.1158/2159-8290.22540583.v1
https://doi.org/10.1158/2159-8290.22540583.v1